Zoloft
Company: Pfizer
Approval Status: Approved October 1997
Treatment for: panic disorder/obsessive compulsive disorder
Areas: Pediatrics/Neonatology; Psychiatry/Psychology
Possible similar drugs: Zoloft; Zoloft
General Information
Other Useful Resources
The U.S. Food and Drug Administration (FDA) approved Zoloft for the treatment of obsessive-compulsive disorder in children ages 6 to17 years of age. Zoloft has already been approved for treatment of panic disorder and obsessive-compulsive disorder in adults.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
